Wim Ottevaere
Director/Board Member presso SEQUANA MEDICAL N.V.
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Catherine Moukheibir | F | 64 | 9 anni | |
| Rudy Dekeyser | M | 63 | 7 anni | |
| Douglas Kohrs | M | 66 | 2 anni | |
| Lies Vanneste | F | - | 6 anni | |
| Douglas Minder | M | - | 3 anni | |
| Ian Crosbie | M | 56 | 8 anni | |
| Alexandra Clyde | F | 60 | 2 anni | |
| Pierre Hubert Andre Chauvineau | M | 61 | 6 anni | |
| Michiel van Lookeren Campagne | M | 64 | 2 anni | |
| Markus Heldt | M | 66 | 3 anni | |
| Jacqueline Fielding | F | 60 | 3 anni | |
| Ken MacLeod | M | - | 1 anni | |
| Carlo Boutton | M | - | 2 anni | |
| Timur Resch | M | 42 | 5 anni | |
| Oliver Gödje | M | 60 | 4 anni | |
| Simon Moroney | M | 65 | 3 anni | |
| Martijn Blom | M | 50 | - | |
| Kirsten van Bockstaele | F | 50 | - | |
| Pieter Robrecht Bevernage | M | 56 | 5 anni | |
| Christiaan de Wilde | M | - |
Fujirebio Europe NV
 Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | 18 anni |
| Ids van der Weij | M | - | 1 anni | |
| Andreas Wirth | M | 56 | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Edwin Moses | M | 69 | 14 anni | |
| Russell Greig | M | 71 | - | |
| Peter John Fellner | M | 80 | 5 anni | |
| Marnix Peferoen | M | - | - | |
| Bo Jesper Hansen | M | 66 | 5 anni | |
| Adrian Percy | M | 59 | - | |
| Mats Gunnar Pettersson | M | 78 | 6 anni | |
| Eva-Lotta Allan | F | 65 | 7 anni | |
| Frank Morich | M | 69 |
Fujirebio Europe NV
Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | 2 anni |
| Remi Vermeiren | M | 84 | - | |
| Piet Houwen | M | 57 | - | |
| Hilde Windels | F | 59 | 1 anni | |
| William John Jenkins | M | 77 | - | |
| Patrice Sellès | M | 52 | 4 anni | |
| Jason M. Hannon | M | 52 | - | |
| Roger Perlmutter | M | 71 | 1 anni | |
| Lutgart A. A. van den Berghe | M | 72 | - | |
| Geert Cauwenbergh | M | 70 | 6 anni | |
| Paul Magrez | M | - |
Fujirebio Europe NV
Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | 6 anni |
| Kim Simonsen | M | 67 | 2 anni | |
| Dominique Tersago | M | 62 | 4 anni | |
| Guido Gielen | M | 64 | - | |
| Patrick McDonnell | M | - | 2 anni | |
| Robert Friesen | M | 60 | 1 anni | |
| Johan Heylen | M | 56 | - | |
| Markus L. E. Ewert | M | 64 | - | |
| Dirk Fengels | M | - | 5 anni | |
| Robert Freisen | M | - | 1 anni | |
| Diane Carman | F | 55 | - | |
| Michel Baijot | M | - |
Fujirebio Europe NV
Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | 5 anni |
| Gijs Klarenbeek | M | 47 | - | |
| Diego Angelo | M | - | - | |
| Erwin Sablon | M | 59 | 2 anni | |
| Orlando Antunes | M | - | - | |
| Jorgen Wittendorff | M | - | 3 anni | |
| Robert Zeldin | M | 61 | - | |
| Christian Duby | M | - | - | |
| Annie van Broeckhoven | M | - |
Fujirebio Europe NV
Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | - |
| Gerrit Franciscus Landolt | M | 60 | 14 anni | |
| John Berriman | M | 76 | 3 anni | |
| Werner Cautreels | M | 71 |
Fujirebio Europe NV
Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | 7 anni |
| Stephen William Bunting | M | 71 | - | |
| Philippe Archinard | M | 63 |
Fujirebio Europe NV
Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | 10 anni |
| Denis Lucquin | M | 67 | 11 anni | |
| Frank Bulens | M | 61 | 8 anni | |
| Jim van Heusden | M | 53 | - | |
| Erik Amble | M | 72 | - | |
| Ignace Lasters | M | - |
Fujirebio Europe NV
Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | - |
| Andreas Menrad | M | 66 | 1 anni | |
| Deborah Law | M | - | 1 anni | |
| Luc Basstanie | M | - | - | |
| Antonin Rollet de Fougerolles | M | 59 | 5 anni | |
| Filip Goossens | M | - |
Fujirebio Europe NV
Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | 6 anni |
| Josefin-Beate Holz | M | 59 | 6 anni | |
| Marc van Dijk | M | 61 |
Fujirebio Europe NV
Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | 3 anni |
| Vera Goossens | M | - |
Fujirebio Europe NV
Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | 5 anni |
| Lieve Nuytinck | M | - |
Fujirebio Europe NV
Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | - |
| Mike Stepan | M | - | 3 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Belgio | 80 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Wim Ottevaere
- Contatti personali
